National and Kapodistrian University of Athens
Μηχανισμοί ανοσοδιαφυγής κατά την καρκινογένεση
Abstract
dc:descriptionInvasive breast carcinoma is the most common malignancy among women worldwide. The study of CD8+ T lymphocytes in the tumor microenvironment is an important prognostic marker; however, their quantitative assessment alone is insufficient. The functional status of CD8+ T lymphocytes, as well as the expression of TCF1 by CD8+ TILs and the clinical impact they may have in breast cancer patients, remain unclear.For the purposes of this doctoral thesis, well-characterized tissue microarrays from 791 patients with invasive breast carcinoma without preoperative treatment were analyzed. Immunophenotypic analysis focused on the expression of CD8+, CD8+ Ki67+, and CD8+ TCF1+ T lymphocytes. Additionally, the expression of the transcription factor TCF1 was examined in stromal cells as well as in cancer cells across all molecular subtypes of breast cancer.The analysis revealed distinct expression patterns among the molecular subtypes, with increased levels of CD8+ T lymphocytes and a reduced proportion of CD8+ Ki67+ T lymphocytes in triple-negative (TNBC) and HER2+ tumors compared to Luminal subtypes. Moreover, high levels of CD8+, CD8+ Ki67+, and CD8+ TCF1+ T cells were associated with longer disease-free survival (DFS). The prognostic impact differed by subtype, showing improved prognosis only in TNBC patients compared to Luminal A. Multivariate Cox regression analysis performed exclusively on TNBC cases showed that increased frequencies of CD8+ (HR = 0.542; 95% CI 0.309–0.950; p = 0.032) and CD8+ TCF1+ cells (HR = 0.280; 95% CI 0.101–0.779; p = 0.015) were independently associated with reduced relapse risk. In Luminal A cases, a higher ratio of CD8+ Ki67+ / CD8+ cells was linked to a lower relapse rate (HR = 0.405; 95% CI 0.169–0.974; p = 0.043).This study reveals a unique profile of proliferating CD8+ T cells, including CD8+TCF1+ cells, which may predict recurrence differently in luminal type A and triple-negative breast cancer patients. Moreover, it highlights the importance of providing functional insights into tumor-infiltrating lymphocytes (TILs), rather than merely assessing their quantity. The latter could help in developing novel biomarkers with clinical impact in breast cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntostoglou, Konstantinos
- Ντόστογλου, Κωνσταντίνος
Subjects
dc:subject × 20- Λεμφοκύτταρα που διηθούν τον όγκο
- Φαινότυπος Τ λεμφοκυττάρων
- Αυλικού τύπου καρκίνωμα του μαστού
- Τριπλά αρνητικό καρκίνωμα του μαστού
- Tumor-infiltrating lymphocytes
- T cell state
- Luminal breast cancer
- Triple-negative breast cancer
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ανοσολογία
- Παθολογοανατομία
- Κλινική Ιατρική
- Ογκολογία
- Basic Medicine
- Medical and Health Sciences
- Immunology
- Pathology
- Clinical Medicine
- Oncology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59882